Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • lizdan_7 lizdan_7 Jun 27, 2012 4:51 PM Flag

    Complete over reaction News GOOD,we will bounce

    Why have a phase 3 if pase 2 was no good, BECAUSE phase two was what they were looking for.

    Enrollment completion of the Phase 2b stage and transition to the Phase 3 stage are expected later this year.
    In response, our team designed an innovative trial – a highly-powered, Phase 2b ‘learning’ stage followed, in an operationally continuous manner, by a Phase 3 ‘confirming’ stage. We believe that the encouraging results reported today support the therapeutic potential of ganetespib, and the operationally adaptive approach allows us to advance quickly to the next step.

 
SNTA
2.25+0.04(+1.81%)Jul 7 4:00 PMEDT